IMPORTANT ANTI DOPING NOTICE - Changes to Prescribing Practices
Tuesday 29 June 2010
It has come to the attention of UK Anti-Doping that prescribing practices might be changing in some of the regions, and that this may result in athletes being offered a different type of medication in their repeat prescription. We would like to remind athletes to check all medication carefully including repeat prescriptions, to ensure that they don't contain prohibited substances. Medications can be checked on Global DRO – www.globaldro.com.
An example of this change is in asthma inhalers. In some circumstances the inhaler prescribed has changed from one that contains Salmeterol (Seretide) to one that contains Formoterol (Fostair) for both single and combination asthma inhalers. In this case, inhalers containing Formoterol would require a Therapeutic Use Exemption (TUE) application, whereas Salbutamol inhalers require a Declaration of Use.
If you require further information, please contact Sophie Thomas at the BEF on telephone number 02476 698874.